| Politician | Action | Description | Traded |
|---|---|---|---|
| Buy | 10X GENOMICS INC. CL A SHS C | May 22, 2026 | |
| Buy | 10X GENOMICS INC CLASS A CMN | May 22, 2026 | |
| Buy | 10X GENOMICS CL A $0.00001 P | May 21, 2026 | |
| Sell | 10X GENOMICS INC CMN | Dec 19, 2025 | |
| Buy | TAKEDA PHARMACEUTICAL CO LTD | Dec 13, 2023 | |
| Sell | 10X GENOMICS INC | Dec 13, 2023 | |
| Buy | 10X GENOMICS INC CMN | Sep 26, 2023 | |
| Buy | 10X GENOMICS INC CMN | Sep 26, 2023 | |
| Sell | TenShare Technology, AI & De | Sep 20, 2021 | |
| Sell | 10X GENOMICS INC REG SHS CL | Oct 20, 2020 |
This page tracks congressional stock trading activity in 10x Genomics, Inc. (TXG) in the Healthcare sector. Disclosed Capitol has indexed 10 disclosed congressional trades involving TXG. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of June 2026 — Disclosed Capitol has tracked 10 disclosed congressional trades in 10x Genomics, Inc. (TXG) — 6:4 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| May 22, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| May 22, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| May 21, 2026 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Dec 19, 2025 | Nicole Malliotakis | R | Sell | $1,001 - $15,000 |
| Dec 13, 2023 | Ro Khanna | D | Buy | $1,001 - $15,000 |
| Dec 13, 2023 | Michael McCaul | R | Sell | $1,001 - $15,000 |
| Sep 26, 2023 | Richard W. Allen | R | Buy | $50,001 - $100,000 |
| Sep 26, 2023 | Richard W. Allen | R | Buy | $15,001 - $50,000 |
| Sep 20, 2021 | Thomas Suozzi | D | Sell | $15,001 - $50,000 |
| Oct 20, 2020 | Phil Roe | R | Sell | $1,001 - $15,000 |
Across the 10 disclosed congressional trades in 10x Genomics, Inc. (TXG), members of Congress have reported 6 buys and 4 sells. The average 30-day alpha vs. the S&P 500 is 10.01%.
As of September 2026, 10x Genomics, Inc. has 70 federal contract award records on file from USAspending.gov — most recently $199K from the Department of Veterans Affairs on 2026-09-28.
| Award date | Agency | Amount |
|---|---|---|
| 2026-09-28 | Department of Veterans Affairs | $199K |
| 2026-09-28 | Department of Health and Human Services · National Institutes of Health | $301K |
| 2026-09-23 | Department of Health and Human Services · National Institutes of Health | $95K |
| 2026-09-23 | Department of Health and Human Services · National Institutes of Health | $53K |
| 2026-09-22 | Department of Health and Human Services · National Institutes of Health | $250K |
| 2026-09-21 | Department of Health and Human Services · National Institutes of Health | $120K |
| 2026-09-18 | Department of Health and Human Services · National Institutes of Health | $60K |
| 2026-09-18 | Department of Health and Human Services · National Institutes of Health | $37K |
| 2026-09-18 | Department of Health and Human Services · National Institutes of Health | $60K |
| 2026-09-14 | Department of Health and Human Services · National Institutes of Health | $53K |
Negative amounts are contract de-obligations. Browse and filter every award on the government contracts page.
For fiscal year 2025, 10x Genomics, Inc. reported revenue of $642.8M and net income of -$43.5M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $301.9M, net income -$31.4M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.